| Financial Year |
March 31 2023 |
| Monetary Funds |
4,588,157,544.12 |
| Held-for-trading Financial Assets |
94,907,212.61 |
| Notes Receivable |
4,112,138.00 |
| Accounts Receivable |
1,501,080,840.72 |
| Advances to Suppliers |
291,445,797.59 |
| Other Receivables |
115,413,865.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,187,084.82 |
| Inventories |
1,426,307,464.82 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
237,639,675.31 |
| Total Current Assets |
8,334,637,468.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
35,522,879.61 |
| Investment Properties |
741,592,824.93 |
| Fixed Assetes |
1,444,629,967.11 |
| Under-construction Projects |
2,022,995,405.23 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,128,593,791.73 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
53,942,398.82 |
| Deferred Income Tax Assets |
48,893,342.61 |
| Other Non-Current Assets |
1,834,225,097.30 |
| Sub-Total of Non-Current Assets |
7,707,458,701.65 |
| Total Assets |
16,042,096,170.22 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
332,630,682.03 |
| Accounts Payable |
3,364,625,807.25 |
| Accounts Received In Advance |
17,514,651.14 |
| Employee Compensation Payable |
213,074,004.55 |
| Taxes Payable |
27,457,290.74 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
407,748,542.13 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
35,927,302.11 |
| Other Current Liabilities |
7,449,523.36 |
| Sub-Total of Current Liabilities |
5,479,559,055.48 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
16,602,973.67 |
| Special Payable |
-- |
| Estimatied Liabilities |
19,085.50 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
2,067,600.00 |
| Sub-Total of Non-Current Liabilities |
573,200,070.29 |
| Total Liabilities |
6,052,759,125.77 |
| Paid-In Capital(Or Share Stock) |
1,023,203,749.00 |
| Capital Surplus |
2,762,476,730.80 |
| Surplus Reserve |
387,299,780.85 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
6,230,187,823.49 |
| Minority Stockholder's Interest |
41,058,779.74 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,948,278,264.71 |
| Owner's Equity（Stockholder's Equity） |
9,989,337,044.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
16,042,096,170.22 |
